- Updated: Clinical Guidance: Stimulant use (11/20/25)
- Topics, Trends & Updates for November (11/13/25)
- Updated: Primary Care for Adults With HIV (11/11/25)
- Updated: Virologic and Immunologic Monitoring in HIV Care (10/31/25)
- Updated: Therapeutic Use of Medical Cannabis in New York State (10/30/25)
- Updated: PrEP to Prevent HIV and Promote Sexual Health (10/16/25)
- Topics, Trends & Updates for October (10/9/25)
- Conversations with CEI Podcast: PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned (11/20/25)
- CEI Newsletter (11/18/25)
- CEI New Online Accredited Courses & Learning Modules (11/18/25)
- Conversations with CEI Podcast: Keeping an Eye on STIs – Have You Heard of TMVII? (11/13/25)
- NYS Medicaid Update (11/3/25)
- NYSDOH AI: Register for the 2025 ETE Summit & World AIDS Day Summit (10/29/2025)
- NYSDOH AI Dear Provider Letter: Community Spread of Clade I Mpox Within California (10/24/25)
Join Drs. Eileen Scully and Christopher Hoffmann for their biweekly case-based podcast to explore quandaries in adult HIV care.
- Case 11. Unfolding Stories to Untangle Syphilis Testing (11/25/25)
- Case 10. A Growing Problem: ART-Associated Weight Gain (11/11/25)
- Case 9. A New TRIO to Reduce ART Complexity (10/28/25)
- Case 8. Charting a Path Forward (10/14/25)
- Case 7. Newer Kids on the Block: Novel ARVs for Multidrug Resistance (9/30/25)
- Case 6. Is More Really More? Optimizing Options for a Healthy Patient (9/16/25)
- Case 5. The Heart of the Matter: Cardiovascular Disease Risk in HIV (9/2/25)
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program is a longstanding, collaborative effort of the AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.
The program produces and publishes evidence-based, state-of-the-art clinical practice guidelines that establish uniform standards of care for NYS to improve the health and well-being of all adults who receive prevention services or treatment for HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders. Learn more:
- 12/05/2025: NAHEWD: Bridging HIV & SUD: Psychedelic-assisted treatments for Substance Use Disorders and Mental Health
- 12/06/2025: ISAM Americas Summit – 2025 Annual Conference
- 12/09/2025: NYSDOH AI: 2025 Annual Ending the Epidemic Summit
- 12/10/2025: NYSDOH AI: 2025 Annual World AIDS Day Event
- 12/14/2025: 2025 Ryan White HIV/AIDS Program Clinical Conference
- 02/22/2026: CROI 2026
- 04/21/2026: NaLa Conference
- 04/23/2026: ASAM 57th Annual Conference: Innovations in Addiction Medicine and Science
- 12/02/2025: Extended-Release Buprenorphine for Opioid Use Disorder
- 12/02/2025: Latest Updates in Expedited Partner Treatment (EPT) in New York State
- 12/08/2025: 2025 World AIDS Day and Ending the Epidemic Summit: A Virtual Clinician Forum
- 12/12/2025: HepCure and CEI co-sponsored Webinar: Hepatitis C and Injection Drug Use
- 12/16/2025: Buprenorphine in Practice: A Case-based Discussion
- 12/17/2025: Stimulant Use Disorder: Clinical Practice Guidelines for the Primary Care Provider
- 01/12/2026: Mpox: What We Knew, What We Learned, and What is Still Unknown
- For the full range of CME options, see the CEI course page.
